Verona Pharma plc (VRP.L) (LON:VRP) Stock Price Up 5.8% – Time to Buy?

Verona Pharma plc (VRP.L) (LON:VRP)’s stock price rose 5.8% on Wednesday . The stock traded as high as GBX 56 ($0.71) and last traded at GBX 55 ($0.70). Approximately 70,791 shares were traded during trading, a decline of 53% from the average daily volume of 150,610 shares. The stock had previously closed at GBX 52 ($0.66).

Verona Pharma plc (VRP.L) Trading Up 5.8 %

The company has a debt-to-equity ratio of 6.85, a quick ratio of 2.47 and a current ratio of 2.99. The firm has a 50 day simple moving average of GBX 55 and a two-hundred day simple moving average of GBX 55. The firm has a market capitalization of £228.00 million and a P/E ratio of -1.68.

About Verona Pharma plc (VRP.L)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.